🇺🇸 FDA
Pipeline program

Topical Minocycline Foam FXFM244

0041-10LND /FX2010-02

Phase 2 small_molecule terminated

Quick answer

Topical Minocycline Foam FXFM244 for Rosacea is a Phase 2 program (small_molecule) at VYNE Therapeutics with 1 ClinicalTrials.gov record(s).

Program details

Company
VYNE Therapeutics
Indication
Rosacea
Phase
Phase 2
Modality
small_molecule
Status
terminated

Clinical trials